指南与共识自身免疫性与大疱性皮肤病

皮肤硬化性疾病诊断与治疗共识第一部分:局限性硬皮病、系统性硬化症及重叠综合征

Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes.
指南 / 共识 · J Eur Acad Dermatol Venereol · 2024-03-08

该共识更新了2017年欧洲皮肤病论坛指南,聚焦局限性硬皮病、系统性硬化症及重叠综合征。共识详述了特征性临床与组织病理学表现、诊断评分及有助于鉴别诊断的血清自身抗体,并更新了一线和进阶治疗策略,为临床医生提供诊疗概述。

要点

  • 共识涵盖局限性硬皮病、系统性硬化症及重叠综合征的诊疗更新
  • 强调特征性临床与组织病理学特征及诊断评分
  • 血清自身抗体有助于鉴别诊断,并更新了一线和进阶治疗策略

核心结论

  • 共识更新了2017年欧洲皮肤病论坛指南,为局限性硬皮病、系统性硬化症及重叠综合征提供诊断与治疗概述。

研究设计与样本

  • 欧洲皮肤病论坛共识声明,更新2017年指南,聚焦皮肤硬化性疾病的诊断与治疗。

主要发现

  • 皮肤硬化性疾病根据皮肤和皮肤外受累表现为不同临床亚型,有时难以相互区分。

关键数值与推荐

  • 共识详述了特征性临床和组织病理学特征、诊断评分及最有助于鉴别诊断的血清自身抗体。

临床怎么用

  • 共识提供了局限性和系统性硬化症的一线和进阶治疗策略更新,指导临床诊疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The term 'sclerosing diseases of the skin' comprises specific dermatological entities, which have fibrotic changes of the skin in common. These diseases mostly manifest in different clinical subtypes according to cutaneous and extracutaneous involvement and can sometimes be difficult to distinguish from each other. The present consensus provides an update to the 2017 European Dermatology Forum Guidelines, focusing on characteristic clinical and histopathological features, diagnostic scores and the serum autoantibodies most useful for differential diagnosis. In addition, updated strategies for the first- and advanced-line therapy of sclerosing skin diseases are addressed in detail. Part 1 of this consensus provides clinicians with an overview of the diagnosis and treatment of localized scleroderma (morphea), and systemic sclerosis including overlap syndromes.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Knobler R, Geroldinger-Simić M, Kreuter A, et al. Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes. J Eur Acad Dermatol Venereol. 2024. PMID: 38456584. doi:10.1111/jdv.19912

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。